Silence Therapeutics (SLN) EPS (Weighted Average and Diluted): 2022-2025
Historic EPS (Weighted Average and Diluted) for Silence Therapeutics (SLN) over the last 2 years, with Sep 2025 value amounting to -$0.15.
- Silence Therapeutics' EPS (Weighted Average and Diluted) rose 40.00% to -$0.15 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.45, marking a year-over-year increase of 17.35%. This contributed to the annual value of -$0.33 for FY2024, which is 32.65% up from last year.
- Latest data reveals that Silence Therapeutics reported EPS (Weighted Average and Diluted) of -$0.15 as of Q3 2025, which was up 21.05% from -$0.19 recorded in Q2 2025.
- Over the past 5 years, Silence Therapeutics' EPS (Weighted Average and Diluted) peaked at $0.09 during Q4 2024, and registered a low of -$0.25 during Q3 2024.
- Over the past 3 years, Silence Therapeutics' median EPS (Weighted Average and Diluted) value was -$0.15 (recorded in 2025), while the average stood at -$0.12.
- Per our database at Business Quant, Silence Therapeutics' EPS (Weighted Average and Diluted) spiked by 166.92% in 2024 and then plummeted by 900.00% in 2025.
- Quarterly analysis of 4 years shows Silence Therapeutics' EPS (Weighted Average and Diluted) stood at -$0.16 in 2022, then increased by 13.69% to -$0.13 in 2023, then skyrocketed by 166.92% to $0.09 in 2024, then spiked by 40.00% to -$0.15 in 2025.
- Its last three reported values are -$0.15 in Q3 2025, -$0.19 for Q2 2025, and -$0.20 during Q1 2025.